Olema Pharmaceuticals, Inc. logo OLMA - Olema Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $28.33 DETAILS
HIGH: $35.00
LOW: $20.00
MEDIAN: $30.00
CONSENSUS: $28.33
UPSIDE: 320.33%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0 0.1 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 (0.1) (0.2) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 57.8 49.2 43.2 40.0 43.9 30.6 32.3 33.2 29.1 29.9 25.9 19.5 18.0 22.8 21.6 17.6 27.1 16.0 16.0 12.5 11.9 10.7 6.3 4.7 1.9 0.8 0.9
SG&A Expenses 9.4 8.6 6.9 5.9 4.0 4.2 4.5 4.4 4.4 4.5 4.5 3.9 3.6 6.8 5.6 5.6 6.2 7.2 5.8 5.2 4.6 4.8 3.8 3.2 0.5 0.2 0.1
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 67.2 57.9 49.9 45.9 47.9 34.9 36.8 37.6 33.5 34.3 30.4 23.3 21.6 29.6 27.2 23.2 33.3 23.3 21.8 17.8 16.5 15.4 10.1 7.9 2.5 1.0 1.0
Operating Income
Operating Income (67.2) (58.0) (50.1) (45.9) (47.9) (34.9) (36.8) (37.6) (33.5) (34.3) (30.4) (23.3) (21.6) (29.6) (27.2) (23.2) (33.3) (23.3) (21.8) (17.8) (16.5) (15.4) (10.1) (7.9) (2.5) (1.0) (1.0)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0
Interest Income 4.5 4.8 4.0 3.6 4.0 4.5 3.3 2.9 3.1 3.4 3.6 1.9 1.6 1.3 1.0 0.6 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0
Profitability
EBITDA (63.1) (53.0) (45.9) (42.2) (43.7) (30.3) (33.5) (34.5) (30.3) (30.9) (26.7) (21.4) (20.0) (28.2) (26.1) (22.6) (32.8) (22.9) (21.6) (17.7) (16.4) (15.4) (10.1) (7.8) (2.5) (1.0) (1.0)
EBIT (63.2) (53.1) (46.1) (42.2) (43.8) (30.4) (33.6) (34.6) (30.4) (31.0) (26.8) (21.5) (20.1) (28.3) (26.2) (22.7) (32.9) (23.0) (21.6) (17.7) (16.4) (15.4) (10.1) (7.8) (2.5) (1.0) (1.0)
Income Before Tax (63.2) (53.1) (46.1) (42.2) (43.8) (30.4) (33.6) (34.6) (30.4) (31.0) (26.8) (21.5) (20.1) (28.3) (26.2) (22.7) (32.9) (23.0) (21.6) (17.7) (16.4) (15.3) (10.1) (7.8) (2.5) (1.7) (1.0)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (63.2) (53.1) (46.1) (42.2) (43.8) (30.4) (33.6) (34.6) (30.4) (31.0) (26.8) (21.5) (20.1) (28.3) (26.2) (22.7) (32.9) (23.0) (21.6) (17.7) (16.4) (15.3) (10.1) (7.8) (2.5) (1.7) (1.0)
Per Share Data
EPS (Basic) -0.61 -0.52 -0.50 -0.49 -0.51 -0.36 -0.57 -0.60 -0.54 -0.56 -0.49 -0.48 -0.49 -0.67 -0.63 -0.55 -0.82 -0.57 -0.54 -0.45 -0.42 -0.39 -0.50 -0.21 -0.17 -0.12 -0.07
EPS (Diluted) -0.61 -0.52 -0.51 -0.49 -0.51 -0.36 -0.57 -0.60 -0.54 -0.56 -0.49 -0.48 -0.49 -0.67 -0.63 -0.55 -0.82 -0.57 -0.54 -0.45 -0.42 -0.39 -0.50 -0.21 -0.17 -0.12 -0.07
Shares Outstanding 104.5 102.8 91.3 85.7 85.5 85.4 58.7 57.3 56.3 55.6 54.8 45.0 40.7 40.4 40.2 40.0 39.9 39.8 39.7 39.6 39.4 39.3 20.2 37.5 14.1 14.1 14.1
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2019 Q4
Current Assets
Cash & Cash Equivalents 48.6 52.5 48.3 35.3 52.5 50.6 139.5 35.9 16.9 33.7 68.5 117.4 35.0 40.9 23.7 26.8 24.5 21.5 13.8 25.6 50.4 47.9 338.5 127.8 0.1
Short-Term Investments 412.5 452.8 457.1 293.7 309.4 342.1 294.6 178.9 222.2 215.3 193.3 159.5 132.5 145.0 180.7 195.8 216.2 246.4 273.4 280.4 267.7 279.1 0 0 0
Net Receivables 0 3.4 4.1 3.0 2.7 1.9 2.1 0.7 0.8 0.7 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 8.8 1.2 1.6 0.6 0.4 0.3 0.4 0.2 0.2 0.2 1.7 3.5 2.7 1.4 1.8 1.6 1.0 0.5 0.5 0.4 0.5 0.8 0.6 0.3 0.0
Total Current Assets 469.9 513.2 515.5 334.3 367.7 396.7 438.5 218.0 242.2 252.1 266.5 282.0 171.5 189.4 208.9 225.1 243.0 270.2 290.7 308.3 320.9 330.3 342.1 129.1 0.1
Non-Current Assets
Property, Plant & Equipment 0.6 0.9 1.1 1.9 2.2 1.7 2.1 2.4 2.8 3.1 3.3 3.6 3.2 3.6 2.5 4.2 4.5 4.4 4.7 1.0 0.9 0.5 0.1 0.0 0.0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0.7 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 16.1 16.5 16.8 16.2 12.0 10.5 9.8 9.8 9.6 8.5 7.2 7.2 2.9 2.8 4.3 2.8 3.1 2.8 0.5 0.5 0.5 0.5 0.5 1.6 0.0
Total Non-Current Assets 16.7 17.4 18.0 18.1 14.3 13.0 12.5 12.2 12.4 11.6 10.4 10.8 6.1 6.4 6.7 6.9 7.6 7.2 5.3 1.5 1.4 1.0 0.6 1.6 0.0
Total Assets 486.6 530.6 533.4 352.5 382.0 409.6 451.0 230.2 254.6 263.7 276.9 292.8 177.6 195.8 215.6 232.0 250.6 277.4 295.9 309.8 322.2 331.3 342.7 130.7 0.1
Current Liabilities
Account Payables 1.7 3.7 9.3 3.5 0.9 0.2 4.5 2.7 4.4 7.7 2.7 2.2 1.6 0.7 0.4 0.0 0.1 0.3 0.0 0.3 0.4 0.4 0.7 0.1 0.9
Short-Term Debt 0.7 1.0 1.1 0 0 0 1.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 0.0 42.5 32.0 5.3 3.4 1.6 30.3 3.8 2.5 1.3 5.5 0.1 0.1 0.1 0.1 0.1 2.4 1.3 0.3 2.6 2.1 1.2 0.4 0.2 0.4
Total Current Liabilities 53.0 47.2 51.8 41.7 33.2 26.1 41.8 30.7 26.5 26.2 21.6 16.0 14.8 19.4 16.5 12.6 12.3 10.2 9.0 8.9 8.1 5.3 4.6 5.3 1.4
Non-Current Liabilities
Long-Term Debt 0 0 0.1 3 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 3 3 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.3
Total Non-Current Liabilities 3 3 3.1 3.3 3.6 0.1 0.3 0.6 0.9 1.2 1.4 1.7 1.2 1.4 1.6 1.7 2.0 2.2 2.4 0 0 0 0 0 9.3
Total Liabilities 56.0 50.2 54.9 45.0 36.8 26.2 42.0 31.3 27.4 27.4 23.1 17.7 16.0 20.8 18.1 14.3 14.3 12.3 11.4 8.9 8.1 5.3 4.6 5.3 10.7
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0
Retained Earnings (713.8) (650.6) (597.6) (551.5) (509.3) (465.5) (435.1) (401.5) (367.0) (336.6) (305.6) (278.9) (257.4) (237.3) (209.0) (182.8) (160.1) (127.2) (104.2) (82.6) (64.8) (48.4) (33.1) (23.0) (10.8)
Accumulated Other Comprehensive Income (0.9) (0.5) 0.6 0.5 0.3 0.4 0.1 0.5 (0.1) (0.0) 0.3 (0.2) (0.5) (1.0) (1.8) (2.7) (2.4) (1.6) (0.1) 0.0 (0.0) (0.0) 0 0 (0.1)
Total Stockholders' Equity 430.6 480.5 478.6 307.5 345.2 383.5 409.0 198.9 227.2 236.3 253.9 275.1 161.6 175.0 197.5 217.7 236.3 265.1 284.6 300.9 314.1 326.0 338.1 125.4 (10.6)
Total Liabilities & Equity 486.6 530.6 533.4 352.5 382.0 409.6 451.0 230.2 254.6 263.7 276.9 292.8 177.6 195.8 215.6 232.0 250.6 277.4 295.9 309.8 322.2 331.3 342.7 130.7 0.1
Debt Metrics
Total Debt 0.7 1.0 1.2 4.5 4.8 1.1 1.4 1.7 2.0 2.2 2.4 2.6 2.0 2.3 2.6 2.8 3.1 3.0 3.3 0 0 0 0 0 0
Net Debt (47.9) (51.6) (47.1) (30.8) (47.7) (49.5) (138.1) (34.2) (14.9) (31.5) (66.1) (114.8) (33.0) (38.6) (21.1) (24.0) (21.4) (18.5) (10.5) (25.6) (50.4) (47.9) (338.5) (127.8) (0.1)
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4
Operating Activities
Net Income (63.2) (53.1) (46.1) (42.2) (43.8) (30.4) (33.6) (34.6) (30.4) (31.0) (26.8) (21.5) (20.1) (28.3) (26.2) (22.7) (32.9) (23.0) (21.6) (17.7) (16.4) (15.3) (10.1) (7.8) (2.5) (1.7) (1.0)
Depreciation & Amortization 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Stock-Based Compensation 12.9 0 4.3 4.2 4.7 4.4 6.3 5.6 5.7 4.9 4.4 4.1 0 0 4.9 0 0 0 4.6 4.2 0 3.2 0 0 0.2 0 0
Change in Working Capital (0.1) (2.2) 4.1 4.4 10.5 (16.3) 2.2 3.5 (1.1) 4.5 5.8 (4.6) (5.5) 3.7 1.8 0.2 1.3 (0.3) (2.9) 1.3 3.5 1.0 (1.3) (0.3) 1.1 (1.1) 0.2
Other Non-Cash Items 4.4 9.2 (0.9) (1.0) (1.4) (1.8) (1.3) (1.7) (1.9) (2.1) (1.9) 0.3 3.4 4.1 (0.2) 4.4 5.0 5.3 1.3 0.1 4.0 0.1 2.4 0.6 0 0.6 0
Operating Cash Flow (45.9) (46.0) (38.3) (34.5) (29.9) (44.0) (26.3) (27.0) (27.6) (23.5) (18.5) (22.7) (22.1) (20.4) (19.7) (18.0) (26.5) (17.9) (18.6) (12.1) (8.9) (11.1) (9.0) (7.5) (1.2) (2.1) (0.8)
Investing Activities
Capital Expenditure 0 0 0 0 0 0 0 0 (0.0) (0.2) 0 0 0 0 (0.2) (0.1) (0.0) (0.0) (0.7) (0.1) (0.4) (0.4) (0.1) 0.0 (0.0) (0.0) 0
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0
Purchases of Investments (48.2) (69.9) (253.4) (71.7) (32.9) (142.9) (189.2) (47.5) (82.2) (76.1) (84.9) (96.0) (50.4) (24.4) (44.5) (18.4) (27.6) (123.2) (20.0) (132.1) (54.7) (280.2) 0 0 0 0 0
Sales/Maturities of Investments 89.3 74.5 91.2 88.9 67.1 97.8 74.8 93.4 77.3 56.1 54 70.5 64.5 61.8 61.0 38.8 57 148.8 26.7 119.4 66 1 0 0 0 0 0
Other Investing Activities (0.2) 0 0 0 0 0 0 0 0 0 0 0.0 0 0 0 0 0 0 0 0 0 (0.5) 0 0 0 0 0
Investing Cash Flow 40.8 4.5 (162.2) 17.3 34.2 (45.1) (114.4) 45.9 (4.9) (20.1) (30.9) (25.4) 14.1 37.4 16.3 20.2 29.4 25.6 6 (12.8) 10.9 (279.6) (0.1) 0.0 (0.0) (0.0) 0
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 3 0
Stock Repurchased 4.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (2.3) 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 (4.4) 0 0 (3.5) 0 0.8 0 0.7 0.9 0.5 0.9 0 0 0 0 0 0 0 0 0 0 (0.1) 0.1 0 0 0
Financing Cash Flow 1.1 45.7 213.6 0.0 (2.5) 0.2 244.3 0.1 15.6 8.8 0.5 130.6 2.0 0.2 0.3 0.1 0.1 0.0 0.8 0.1 0.5 0 219.8 84.9 23.8 30.0 0
Cash Position
Net Change in Cash (3.9) 4.2 13.0 (17.2) 1.8 (88.8) 103.6 19.0 (16.8) (34.8) (48.9) 82.4 (6.0) 17.2 (3.1) 2.3 3.0 7.7 (11.8) (24.8) 2.5 (290.7) 210.7 127.8 22.6 27.8 (0.8)
Cash at Beginning 52.5 48.3 35.3 52.5 50.6 139.5 35.9 16.9 33.7 68.5 117.4 35.0 40.9 23.7 26.8 24.5 21.5 13.8 25.6 50.4 47.9 338.5 127.8 0 27.9 0.1 0.9
Cash at End 48.6 52.5 48.3 35.3 52.5 50.6 139.5 35.9 16.9 33.7 68.5 117.4 35.0 40.9 23.7 26.8 24.5 21.5 13.8 25.6 50.4 47.9 338.5 127.8 50.5 27.9 0.1
Free Cash Flow (45.9) (46.0) (38.3) (34.5) (29.9) (44.0) (26.3) (27.0) (27.6) (23.6) (18.5) (22.7) (22.1) (20.4) (19.9) (18.1) (26.5) (17.9) (19.3) (12.2) (9.3) (11.5) (9.1) (7.5) (1.2) (2.1) (0.8)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 (0.1) (0.2) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (67.2) (58.0) (50.1) (45.9) (47.9) (34.9) (36.8) (37.6) (33.5) (34.3) (30.4) (23.3) (21.6) (29.6) (27.2) (23.2) (33.3) (23.3) (21.8) (17.8) (16.5) (15.4) (10.1) (7.9) (2.5) (1.0) (1.0)
Net Income (63.2) (53.1) (46.1) (42.2) (43.8) (30.4) (33.6) (34.6) (30.4) (31.0) (26.8) (21.5) (20.1) (28.3) (26.2) (22.7) (32.9) (23.0) (21.6) (17.7) (16.4) (15.3) (10.1) (7.8) (2.5) (1.7) (1.0)
EPS (Diluted) -0.61 -0.52 -0.51 -0.49 -0.51 -0.36 -0.57 -0.60 -0.54 -0.56 -0.49 -0.48 -0.49 -0.67 -0.63 -0.55 -0.82 -0.57 -0.54 -0.45 -0.42 -0.39 -0.50 -0.21 -0.17 -0.12 -0.07
Balance Sheet
Cash & Equivalents 48.6 52.5 48.3 35.3 52.5 50.6 139.5 35.9 16.9 33.7 68.5 117.4 35.0 40.9 23.7 26.8 24.5 21.5 13.8 25.6 50.4 47.9 338.5 127.8 0.1
Total Assets 486.6 530.6 533.4 352.5 382.0 409.6 451.0 230.2 254.6 263.7 276.9 292.8 177.6 195.8 215.6 232.0 250.6 277.4 295.9 309.8 322.2 331.3 342.7 130.7 0.1
Total Debt 0.7 1.0 1.2 4.5 4.8 1.1 1.4 1.7 2.0 2.2 2.4 2.6 2.0 2.3 2.6 2.8 3.1 3.0 3.3 0 0 0 0 0 0
Stockholders' Equity 430.6 480.5 478.6 307.5 345.2 383.5 409.0 198.9 227.2 236.3 253.9 275.1 161.6 175.0 197.5 217.7 236.3 265.1 284.6 300.9 314.1 326.0 338.1 125.4 (10.6)
Cash Flow
Operating Cash Flow (45.9) (46.0) (38.3) (34.5) (29.9) (44.0) (26.3) (27.0) (27.6) (23.5) (18.5) (22.7) (22.1) (20.4) (19.7) (18.0) (26.5) (17.9) (18.6) (12.1) (8.9) (11.1) (9.0) (7.5) (1.2) (2.1) (0.8)
Capital Expenditure 0 0 0 0 0 0 0 0 (0.0) (0.2) 0 0 0 0 (0.2) (0.1) (0.0) (0.0) (0.7) (0.1) (0.4) (0.4) (0.1) 0.0 (0.0) (0.0) 0
Free Cash Flow (45.9) (46.0) (38.3) (34.5) (29.9) (44.0) (26.3) (27.0) (27.6) (23.6) (18.5) (22.7) (22.1) (20.4) (19.9) (18.1) (26.5) (17.9) (19.3) (12.2) (9.3) (11.5) (9.1) (7.5) (1.2) (2.1) (0.8)